Redox-generated isoprostanes are associated with residual platelet activity in aspirin-treated patients with stable coronary heart disease.

Abstract

Insufficient platelet inhibition by low-dose aspirin is associated with poor prognosis in patients with coronary heart disease (CHD). We sought to investigate the prevalence of this phenomenon in patients with stable CHD and to study whether oxidative stress plays a role in its pathogenesis.

Bibliografische Daten

OriginalspracheDeutsch
Aufsatznummer12
ISSN1538-7933
StatusVeröffentlicht - 2010
pubmed 20961392